Literature DB >> 8099316

Overexpression of c-fos increases recombination frequency in human osteosarcoma cells.

S van den Berg1, H J Rahmsdorf, P Herrlich, B Kaina.   

Abstract

We have shown previously that overexpression of c-Ha-ras, v-mos or c-fos increases the spontaneous level of chromosomal aberrations and gene mutations in NIH 3T3 cells, and that reduction of the Fos protein level inhibits aberration induction by c-Ha-ras and v-mos and also by irradiation with ultraviolet light (van den Berg et al., Mol. Carcinogenesis, 4, 460-466). In order to examine whether fos is also involved in DNA recombination, thymidine kinase (tk) deficient human osteosarcoma cells containing two versions of the herpes simplex virus tk gene inactivated by base insertion were either transiently or stably transfected with various fos expression plasmids. The frequency of tk+ revertants was significantly enhanced both upon transient transfection with RSV-promoter-fos gene constructs and by stimulation of Fos synthesis in stably transfected cells harbouring an inducible metallothionein promoter-fos construct. No such increases were observed in cells transfected with plasmids containing a truncated version of c-fos. The data indicate that c-fos is involved in generating various types of genetic changes including homologous recombination; a role of c-fos in genetic instability may contribute to its action in tumor promotion and progression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099316     DOI: 10.1093/carcin/14.5.925

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  8 in total

1.  Osteosarcomagenic doses of radium (224Ra) and infectious endogenous retroviruses enhance proliferation and osteogenic differentiation of skeletal tissue differentiating in vitro.

Authors:  J Schmidt; K Heermeier; U Linzner; A Luz; M Silbermann; E Livne; V Erfle
Journal:  Radiat Environ Biophys       Date:  1994       Impact factor: 1.925

2.  Immortalization of normal human gingival keratinocytes and cytological and cytogenetic characterization of the cells.

Authors:  Chikahiro Kubo; Takeo W Tsutsui; Yukiko Tamura; Shin-Ichi Kumakura; Takeki Tsutsui
Journal:  Odontology       Date:  2009-01-29       Impact factor: 2.634

3.  Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma.

Authors:  John Lammli; Minyan Fan; Howard G Rosenthal; Meghan Patni; Elizabeth Rinehart; Gerardo Vergara; Elizabeth Ablah; Paul H Wooley; George Lucas; Shang-You Yang
Journal:  Int Orthop       Date:  2012-08-02       Impact factor: 3.075

4.  Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy.

Authors:  G Kick; G Messer; G Plewig; P Kind; A E Goetz
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

5.  Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9.

Authors:  Qiaozhen Wang; Huancai Liu; Qing Wang; Fenghua Zhou; Yongxin Liu; Yawen Zhang; Haoyu Ding; Meng Yuan; Fengjie Li; Yanchun Chen
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

Review 6.  Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy.

Authors:  Akio Sakamoto; Yukihide Iwamoto
Journal:  Rev Recent Clin Trials       Date:  2008-09

7.  High VEGF with rapid growth and early metastasis in a mouse osteosarcoma model.

Authors:  Shang-You Yang; Haiying Yu; Jeffrey E Krygier; Paul H Wooley; Michael P Mott
Journal:  Sarcoma       Date:  2007

8.  MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS.

Authors:  Zili Wang; Rongzhen He; Hansong Xia; Y U Wei; Song Wu
Journal:  Exp Ther Med       Date:  2016-02-17       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.